Issuance of Stock Acquisition Rights for Directors, Audit & Supervisory Board Members and Employees
First written in FY2017-Q2. 6 of 9 entries say "Advanced", first in FY2017. Latest entry: FY2023-Q1.
4 other companies' latest entry also says "Dropped".
- FY2023-Q1DroppedAnnual report
「The stock acquisition rights approved by the Board of Directors on 27 September 2017 expired on 27 September 2022 upon the end of their exercise period.」
The stock acquisition rights approved on 27 September 2017 expired upon the end of their exercise period. The quarterly report states that there were no applicable stock option plans or other stock acquisition rights. - FY2022RestatedAnnual report
「Number of stock acquisition rights (*) 401 [401] Class, details, and number of shares underlying the stock acquisition rights (*) Common shares 40,100 [40,100] Exercise period of the stock acquisition rights (*) 28 September 2019 to 27 September 2022」
Disclosed the number of outstanding Series 2 stock acquisition rights for officers and employees and their exercise period as of the end of June 2022. - FY2021AdvancedAnnual report
「1 July 2020 to 30 June 2021 Common shares 26,000 Common shares 6,967,500 25,034 1,245,724 25,034 1,218,724」
The exercise of stock acquisition rights resulted in the issuance of 26,000 common shares during the fiscal year and increased both share capital and the capital reserve by ¥25,034 thousand. - FY2021-Q3AdvancedAnnual report
「1 January 2021 to 31 March 2021 1,500 6,967,500 1,530 1,245,724 1,530 1,218,724 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the total number of issued shares by 1,500 shares and increased both share capital and the capital reserve by ¥1,530 thousand during the cumulative third quarter. Stock acquisition rights for officers and employees continued to be exercised at the share issuance stage. - FY2021-Q1AdvancedAnnual report
「1 July 2020 to 30 September 2020 24,500 6,966,000 23,503 1,244,194 23,503 1,217,194 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the total number of issued shares by 24,500 shares and increased both share capital and the capital reserve by ¥23,503 thousand during the cumulative quarter. - FY2020AdvancedAnnual report
「7 May 2020 Common shares 3,000 Common shares 6,941,500 2,852 1,220,690 2,852 1,193,690 (Note 7) Issue of common shares through the exercise of stock acquisition rights.」
On 7 May 2020, 3,000 common shares were issued through the exercise of stock acquisition rights, increasing both share capital and the capital reserve by ¥2,852 thousand. Stock acquisition rights for officers and employees have progressed to the actual share issuance stage. - FY2020-Q1AdvancedAnnual report
「1 July 2019 to 30 September 2019 2,400 6,938,500 2,016 1,217,572 2,016 1,190,572 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the total number of issued shares by 2,400 shares and increased both share capital and the capital reserve by ¥2,016 thousand during the cumulative quarter. - FY2017AdvancedAnnual report
「Number of shares (shares) 62,100 shares (Note 1) Exercise period of the stock acquisition rights 28 September 2019 to 27 September 2022」
Disclosed a new stock option plan based on the resolution of the ordinary general meeting of shareholders held on 27 September 2017, granting 62,100 shares to 4 directors and 35 employees. - FY2017-Q2First statedAnnual report
「Number of stock acquisition rights (rights) 628 (Note 1) Number of shares underlying the stock acquisition rights (shares) 62,800 (Note 1) Exercise price of the stock acquisition rights (yen) 1,680 (Note 2) Exercise period 29 September 2018 to 28 September 2020」
Issued 628 stock acquisition rights approved on 28 September 2016, covering 62,800 common shares. At the time of exercise, the holder must be a director, auditor, or employee of the Company or a subsidiary.